Group One Trading’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.89K | Buy |
8,524
+6,113
| +254% | +$7.09K | ﹤0.01% | 1575 |
|
|
2025
Q1 | $2.65K | Sell |
2,411
-26,437
| -92% | -$29.1K | ﹤0.01% | 1643 |
|
|
2024
Q4 | $49.6K | Sell |
28,848
-93,741
| -76% | -$161K | ﹤0.01% | 1236 |
|
|
2024
Q3 | $304K | Sell |
122,589
-2,435
| -2% | -$6.04K | ﹤0.01% | 604 |
|
|
2024
Q2 | $303K | Buy |
125,024
+96,987
| +346% | +$235K | ﹤0.01% | 578 |
|
|
2024
Q1 | $114K | Buy |
28,037
+20,494
| +272% | +$83K | ﹤0.01% | 784 |
|
|
2023
Q4 | $29K | Buy |
+7,543
| New | +$29K | ﹤0.01% | 1186 |
|
|
2023
Q3 | – | Sell |
-32,800
| Closed | -$158K | – | 1884 |
|
|
2023
Q2 | $158K | Buy |
32,800
+28,500
| +663% | +$137K | ﹤0.01% | 759 |
|
|
2023
Q1 | $17.5K | Sell |
4,300
-9,209
| -68% | -$37.4K | ﹤0.01% | 1219 |
|
|
2022
Q4 | $72.9K | Buy |
13,509
+629
| +5% | +$3.4K | ﹤0.01% | 988 |
|
|
2022
Q3 | $129K | Buy |
+12,880
| New | +$129K | ﹤0.01% | 947 |
|